Campbell Shannon bought ZNTL
May 26, 2026 · Form 4 insider transaction
Campbell Shannon bought 114,200 shares of Zentalis Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
114,200
Price
$0.00
Total value
N/A
InsiderCampbell Shannon
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMay 26, 2026
Filing dateMay 27, 2026
Shares owned after114,200
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The restricted stock units ("RSUs") were granted by the Issuer pursuant to the Issuer's Non-Employee Director Compensation Program. One third of the RSUs will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.